Eastman Chemical jumps as Jefferies boosts target to $89 on margin outlook
Eastman Chemical shares rose as investors reacted to a fresh Jefferies price-target hike to $89 from $80 while reiterating a Buy rating. The analyst cited improving Chemical Intermediates margins from a “steeper cost curve,” lifting 2026 estimates and fueling the stock’s roughly 3% gain.
1. What’s moving the stock
Eastman Chemical (EMN) is trading higher today as a bullish analyst note hit the tape. Jefferies raised its price target on EMN to $89 from $80 and kept a Buy rating, pointing to an improving setup for the company’s Chemical Intermediates segment and lifting its 2026 estimates to reflect better margin expectations. (tipranks.com)
2. The key driver: Chemical Intermediates margins
The Jefferies thesis centers on a “steeper cost curve” that could support Chemical Intermediates profitability and help Eastman defend volumes and potentially gain share even if end-market demand remains pressured. For a cyclical materials name like EMN, incremental changes in segment margin assumptions can meaningfully change forward EPS expectations and sentiment, which often shows up quickly in the stock. (tipranks.com)
3. What to watch next
With the stock reacting to estimate revisions and a higher target, the next catalyst is whether Eastman’s reported results and outlook validate the margin improvement narrative—especially within Chemical Intermediates. Investors will be watching for confirmation that cost advantages are translating into realized spreads and earnings power rather than a temporary benefit that fades with feedstock moves or demand shifts. (tipranks.com)